PALO ALTO, Calif.--(BUSINESS WIRE)--Nov 27, 2024--
Hippocratic AI, the company building the first safety-focused Large Language Model (LLM) for healthcare, today announced the issuance of its first patent. Patent 12,142,371, issued by the US Patent Office this month, covers several innovations incorporated into Polaris, its safety-focused LLM built with a constellation architecture for healthcare.
The Polaris constellation architecture plays a central role in making Hippocratic AI’s system safe. Early single LLM prototypes correctly answered only 80% of questions posed in clinical, non-diagnostic conversations. After the invention of the constellation architecture, Hippocratic AI’s Polaris 1.0 system exceeded human accuracy on critical benchmarks, and its Polaris 2.0 system correctly answered 99.02% of questions posed.
The constellation architecture rests on the idea that the safest way to build an LLM application is to use not one LLM but multiple models that double-check the primary model to ensure accuracy and safety. Since the launch of Polaris 1.0 in Q1, 2024, many AI agents have utilized the same approach.
“The patent highlights not only that Hippocratic AI invented this novel approach, but also the breadth and depth of Hippocratic AI’s innovation,” said Munjal Shah, co-founder and CEO of Hippocratic AI. “We believe the way to ensure safety in healthcare AI – and be true to our “do no harm” mission – is through this unique, novel architecture. I commend the Hippocratic AI team for having the vision, skills, and acumen to develop, patent, and deploy Polaris in under two years – they are truly our most important asset.”
Hippocratic AI’s patent covers key components of the Polaris system, including its constellation architecture, where a main model drives the conversation while other models provide support:
Medication Reconciliation Engine: Patients often mispronounce drug names or leave off entire syllables. If the AI can’t correctly identify what medication the patient is referring to, an error could occur that could hurt a patient. This engine uses a sophisticated set of reasoning steps, patient Q&A, and other techniques to ensure the correct drug and the correct version of a drug (extended-release, etc).
16 other engines designed to ensure safety
These components work together to provide a robust, low-latency conversational AI system tailored for healthcare applications. Specific applications disclosed in the patent include:
These and other Hippocratic AI applications aim to reduce healthcare staff shortages, lower healthcare costs, and allow human medical staff more time to focus on in-person patient engagement, thereby improving overall healthcare delivery and patient satisfaction.
About Hippocratic AI
Hippocratic AI’s mission is to develop the first safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health. The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Washington University in St. Louis, Stanford, Google, and NVIDIA. Hippocratic AI has received a total of $137 million in funding and is backed by leading investors, including General Catalyst, Andreessen Horowitz, Premji Invest, SV Angel, NVentures, and Greycroft. For more information on Hippocratic AI, www.HippocraticAI.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20241127354152/en/
CONTACT: Media:
Rick Keating
rkeating@keatingco.com
917 767 2400
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: HEALTH TECHNOLOGY HEALTH TECHNOLOGY OTHER TECHNOLOGY SOFTWARE GENERAL HEALTH ARTIFICIAL INTELLIGENCE
SOURCE: Hippocratic AI
Copyright Business Wire 2024.
PUB: 11/27/2024 11:00 AM/DISC: 11/27/2024 11:00 AM
http://www.businesswire.com/news/home/20241127354152/en